IL1R2 and neoplasm: Furthermore, cluster 1 exhibited increased expression of IL1R2 and the IL-33 receptor ST2 (IL1RL1), which enhances the proportion and suppressive potential of tumor-infiltrating Treg in HNSCC patients84.